Literature DB >> 11510787

Initial risk class and length of hospital stay in community-acquired pneumonia.

R Menéndez1, D Ferrando, J M Vallés, E Martínez, M Perpiñá.   

Abstract

The total medical costs of community-acquired pneumonia are directly related to the costs of hospital admission and length of stay. The aim of the present study was to evaluate the reasons for prolonged duration of stay in patients stratified in five risk classes for death, and to identify factors associated with prolonged stay. The study population consisted of 295 patients. According to lower (classes I, II, III) or to higher (classes IV, V) risk, the target duration of hospitalization was set at 5 and 7 days, respectively. The causes of prolonged hospitalization were classified as pneumonia-related, complications, unstable comorbid diseases and nonclinical factors. The overall percentage of patients with appropriate duration of hospitalization was 32%. Causes of prolonged hospitalization were related mainly to pneumonia (32%) from all risk classes. Morbid complications and instability of the underlying illness were greater in class V patients. Nonclinical factors were present in 29.5% of cases. Hypoxaemia, anaemia, hypoalbuminaemia, and complications appearing before 72 h were associated with prolonged hospitalization. The cause of prolonged hospitalization of patients with community-acquired pneumonia is multifactorial, depending mainly on pneumonia and comorbid conditions but there is a large number of unnecessary hospitalization days that could be reduced by improving the efficiency of hospital care.

Entities:  

Mesh:

Year:  2001        PMID: 11510787     DOI: 10.1183/09031936.01.00090001

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

1.  Factors associated with length of stay in hospital for suspected community-acquired pneumonia.

Authors:  Jane Q Huang; Peter M Hooper; Thomas J Marrie
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

2.  Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.

Authors:  M M van der Eerden; F Vlaspolder; C S de Graaff; T Groot; W Bronsveld; H M Jansen; W G Boersma
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

3.  Anemia and community-acquired pneumococcal pneumonia.

Authors:  S M Doshi; A M Rueda; V F Corrales-Medina; D M Musher
Journal:  Infection       Date:  2011-05-10       Impact factor: 3.553

4.  Hospital Treatment Costs and Factors Affecting These Costs in Community-Acquired Pneumonia.

Authors:  Fatma Tokgöz Akyıl; Armağan Hazar; İpek Erdem; Canan Pehlivan Öneş; Murat Yalçınsoy; İlim Irmak; Umut Sabri Kasapoğlu
Journal:  Turk Thorac J       Date:  2015-07-01

5.  The Impact of Patient Profiles and Procedures on Hospitalization Costs through Length of Stay in Community-Acquired Pneumonia Patients Based on a Japanese Administrative Database.

Authors:  Hironori Uematsu; Susumu Kunisawa; Kazuto Yamashita; Yuichi Imanaka
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

6.  Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome.

Authors:  R Menéndez; A Torres; R Zalacaín; J Aspa; J J Martín Villasclaras; L Borderías; J M Benítez Moya; J Ruiz-Manzano; F Rodríguez de Castro; J Blanquer; D Pérez; C Puzo; F Sánchez Gascón; J Gallardo; C Alvarez; L Molinos
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

7.  The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia.

Authors:  Michael C Reade; Lisa Weissfeld; Derek C Angus; John A Kellum; Eric B Milbrandt
Journal:  BMC Pulm Med       Date:  2010-03-16       Impact factor: 3.317

8.  Predictors for length of hospital stay in patients with community-acquired pneumonia: results from a Swiss multicenter study.

Authors:  Isabelle Suter-Widmer; Mirjam Christ-Crain; Werner Zimmerli; Werner Albrich; Beat Mueller; Philipp Schuetz
Journal:  BMC Pulm Med       Date:  2012-05-20       Impact factor: 3.317

9.  Lower hemoglobin transfusion trigger is associated with higher mortality in patients hospitalized with pneumonia.

Authors:  Naomi Rahimi-Levene; Maya Koren-Michowitz; Ronit Zeidenstein; Victoria Peer; Ahuva Golik; Tomer Ziv-Baran
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

10.  Use of intravenous antibiotics for the treatment of community-acquired pneumonia in the emergency department.

Authors:  Anita G Carrie; Thomas J Marrie
Journal:  Ther Clin Risk Manag       Date:  2005-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.